Literature DB >> 25142582

Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.

Yahira M Báez-Santos1, Anna M Mielech2, Xufang Deng2, Susan Baker2, Andrew D Mesecar3.   

Abstract

UNLABELLED: The papain-like protease (PLpro) domain from the deadly Middle East respiratory syndrome coronavirus (MERS-CoV) was overexpressed and purified. MERS-CoV PLpro constructs with and without the putative ubiquitin-like (UBL) domain at the N terminus were found to possess protease, deubiquitinating, deISGylating, and interferon antagonism activities in transfected HEK293T cells. The quaternary structure and substrate preferences of MERS-CoV PLpro were determined and compared to those of severe acute respiratory syndrome coronavirus (SARS-CoV) PLpro, revealing prominent differences between these closely related enzymes. Steady-state kinetic analyses of purified MERS-CoV and SARS-CoV PLpros uncovered significant differences in their rates of hydrolysis of 5-aminomethyl coumarin (AMC) from C-terminally labeled peptide, ubiquitin, and ISG15 substrates, as well as in their rates of isopeptide bond cleavage of K48- and K63-linked polyubiquitin chains. MERS-CoV PLpro was found to have 8-fold and 3,500-fold higher catalytic efficiencies for hydrolysis of ISG15-AMC than for hydrolysis of the Ub-AMC and Z-RLRGG-AMC substrates, respectively. A similar trend was observed for SARS-CoV PLpro, although it was much more efficient than MERS-CoV PLpro toward ISG15-AMC and peptide-AMC substrates. MERS-CoV PLpro was found to process K48- and K63-linked polyubiquitin chains at similar rates and with similar debranching patterns, producing monoubiquitin species. However, SARS-CoV PLpro much preferred K48-linked polyubiquitin chains to K63-linked chains, and it rapidly produced di-ubiquitin molecules from K48-linked chains. Finally, potent inhibitors of SARS-CoV PLpro were found to have no effect on MERS-CoV PLpro. A homology model of the MERS-CoV PLpro structure was generated and compared to the X-ray structure of SARS-CoV PLpro to provide plausible explanations for differences in substrate and inhibitor recognition. IMPORTANCE: Unlocking the secrets of how coronavirus (CoV) papain-like proteases (PLpros) perform their multifunctional roles during viral replication entails a complete mechanistic understanding of their substrate recognition and enzymatic activities. We show that the PLpro domains from the MERS and SARS coronaviruses can recognize and process the same substrates, but with different catalytic efficiencies. The differences in substrate recognition between these closely related PLpros suggest that neither enzyme can be used as a generalized model to explain the kinetic behavior of all CoV PLpros. As a consequence, decoding the mechanisms of PLpro-mediated antagonism of the host innate immune response and the development of anti-CoV PLpro enzyme inhibitors will be a challenging undertaking. The results from this study provide valuable information for understanding how MERS-CoV PLpro-mediated antagonism of the host innate immune response is orchestrated, as well as insight into the design of inhibitors against MERS-CoV PLpro.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25142582      PMCID: PMC4248884          DOI: 10.1128/JVI.01294-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.

Authors:  Naina Barretto; Dalia Jukneliene; Kiira Ratia; Zhongbin Chen; Andrew D Mesecar; Susan C Baker
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.

Authors:  Puck B van Kasteren; Ben A Bailey-Elkin; Terrence W James; Dennis K Ninaber; Corrine Beugeling; Mazdak Khajehpour; Eric J Snijder; Brian L Mark; Marjolein Kikkert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

4.  PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway.

Authors:  Gang Wang; Gang Chen; Dahai Zheng; Genhong Cheng; Hong Tang
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

5.  Middle East respiratory syndrome coronavirus in bats, Saudi Arabia.

Authors:  Ziad A Memish; Nischay Mishra; Kevin J Olival; Shamsudeen F Fagbo; Vishal Kapoor; Jonathan H Epstein; Rafat Alhakeem; Abdulkareem Durosinloun; Mushabab Al Asmari; Ariful Islam; Amit Kapoor; Thomas Briese; Peter Daszak; Abdullah A Al Rabeeah; W Ian Lipkin
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

6.  MERS-CoV papain-like protease has deISGylating and deubiquitinating activities.

Authors:  Anna M Mielech; Andy Kilianski; Yahira M Baez-Santos; Andrew D Mesecar; Susan C Baker
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

7.  Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.

Authors:  Kiira Ratia; Andrew Kilianski; Yahira M Baez-Santos; Susan C Baker; Andrew Mesecar
Journal:  PLoS Pathog       Date:  2014-05-22       Impact factor: 6.823

8.  Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential.

Authors:  Eveline Kindler; Hulda R Jónsdóttir; Doreen Muth; Ole J Hamming; Rune Hartmann; Regulo Rodriguez; Robert Geffers; Ron A M Fouchier; Christian Drosten; Marcel A Müller; Ronald Dijkman; Volker Thiel
Journal:  MBio       Date:  2013-02-19       Impact factor: 7.867

Review 9.  Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities.

Authors:  Anna M Mielech; Yafang Chen; Andrew D Mesecar; Susan C Baker
Journal:  Virus Res       Date:  2014-02-07       Impact factor: 3.303

10.  Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease.

Authors:  Holger A Lindner; Viktoria Lytvyn; Hongtao Qi; Paule Lachance; Edmund Ziomek; Robert Ménard
Journal:  Arch Biochem Biophys       Date:  2007-07-14       Impact factor: 4.013

View more
  53 in total

1.  SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.

Authors:  Miklós Békés; Wioletta Rut; Paulina Kasperkiewicz; Monique P C Mulder; Huib Ovaa; Marcin Drag; Christopher D Lima; Tony T Huang
Journal:  Biochem J       Date:  2015-06-01       Impact factor: 3.857

Review 2.  Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.

Authors:  Jasper F W Chan; Susanna K P Lau; Kelvin K W To; Vincent C C Cheng; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

3.  A Naturally Occurring Recombinant Enterovirus Expresses a Torovirus Deubiquitinase.

Authors:  Pengcheng Shang; Saurav Misra; Ben Hause; Ying Fang
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

4.  Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus.

Authors:  Courtney M Daczkowski; Octavia Y Goodwin; John V Dzimianski; Jonathan J Farhat; Scott D Pegan
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  Screening of potent STAT3-SH2 domain inhibitors from JAK/STAT compound library through molecular dynamics simulation.

Authors:  Suryaa Manoharan; Ajithkumar Balakrishnan; Vedagiri Hemamalini; Ekambaram Perumal
Journal:  Mol Divers       Date:  2022-07-13       Impact factor: 3.364

6.  Steady-state kinetic studies reveal that the anti-cancer target Ubiquitin-Specific Protease 17 (USP17) is a highly efficient deubiquitinating enzyme.

Authors:  Nicole M Hjortland; Andrew D Mesecar
Journal:  Arch Biochem Biophys       Date:  2016-10-15       Impact factor: 4.013

7.  Extensive Positive Selection Drives the Evolution of Nonstructural Proteins in Lineage C Betacoronaviruses.

Authors:  Diego Forni; Rachele Cagliani; Alessandra Mozzi; Uberto Pozzoli; Nasser Al-Daghri; Mario Clerici; Manuela Sironi
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

8.  p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.

Authors:  Yue Ma-Lauer; Javier Carbajo-Lozoya; Marco Y Hein; Marcel A Müller; Wen Deng; Jian Lei; Benjamin Meyer; Yuri Kusov; Brigitte von Brunn; Dev Raj Bairad; Sabine Hünten; Christian Drosten; Heiko Hermeking; Heinrich Leonhardt; Matthias Mann; Rolf Hilgenfeld; Albrecht von Brunn
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-12       Impact factor: 11.205

Review 9.  Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle.

Authors:  Jessica Proulx; Kathleen Borgmann; In-Woo Park
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

10.  Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2.

Authors:  Yong Zhao; Yu Tian; Chenling Pan; Aihua Liang; Wei Zhang; Yi Sheng
Journal:  Interdiscip Sci       Date:  2021-07-25       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.